140 related articles for article (PubMed ID: 10074464)
1. Renin inhibition by substituted piperidines: a novel paradigm for the inhibition of monomeric aspartic proteinases?
Oefner C; Binggeli A; Breu V; Bur D; Clozel JP; D'Arcy A; Dorn A; Fischli W; Grüninger F; Güller R; Hirth G; Märki H; Mathews S; M ller M; Ridley RG; Stadler H; Vieira E; Wilhelm M; Winkler F; Wostl W
Chem Biol; 1999 Mar; 6(3):127-31. PubMed ID: 10074464
[TBL] [Abstract][Full Text] [Related]
2. High resolution X-ray analyses of renin inhibitor-aspartic proteinase complexes.
Foundling SI; Cooper J; Watson FE; Cleasby A; Pearl LH; Sibanda BL; Hemmings A; Wood SP; Blundell TL; Valler MJ
Nature; 1987 May 28-Jun 3; 327(6120):349-52. PubMed ID: 3295561
[TBL] [Abstract][Full Text] [Related]
3. Substituted piperidines--highly potent renin inhibitors due to induced fit adaptation of the active site.
Vieira E; Binggeli A; Breu V; Bur D; Fischli W; Güller R; Hirth G; Märki HP; Müller M; Oefner C; Scalone M; Stadler H; Wilhelm M; Wostl W
Bioorg Med Chem Lett; 1999 May; 9(10):1397-402. PubMed ID: 10360744
[TBL] [Abstract][Full Text] [Related]
4. Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin.
Rahuel J; Rasetti V; Maibaum J; Rüeger H; Göschke R; Cohen NC; Stutz S; Cumin F; Fuhrer W; Wood JM; Grütter MG
Chem Biol; 2000 Jul; 7(7):493-504. PubMed ID: 10903938
[TBL] [Abstract][Full Text] [Related]
5. A novel class of oral direct renin inhibitors: highly potent 3,5-disubstituted piperidines bearing a tricyclic p3-p1 pharmacophore.
Ostermann N; Ruedisser S; Ehrhardt C; Breitenstein W; Marzinzik A; Jacoby E; Vangrevelinghe E; Ottl J; Klumpp M; Hartwieg JC; Cumin F; Hassiepen U; Trappe J; Sedrani R; Geisse S; Gerhartz B; Richert P; Francotte E; Wagner T; Krömer M; Kosaka T; Webb RL; Rigel DF; Maibaum J; Baeschlin DK
J Med Chem; 2013 Mar; 56(6):2196-206. PubMed ID: 23360239
[TBL] [Abstract][Full Text] [Related]
6. X-ray structures of five renin inhibitors bound to saccharopepsin: exploration of active-site specificity.
Cronin NB; Badasso MO; J Tickle I; Dreyer T; Hoover DJ; Rosati RL; Humblet CC; Lunney EA; Cooper JB
J Mol Biol; 2000 Nov; 303(5):745-60. PubMed ID: 11061973
[TBL] [Abstract][Full Text] [Related]
7. From peptides to non-peptide peptidomimetics: design and synthesis of new piperidine inhibitors of aspartic peptidases.
Bursavich MG; West CW; Rich DH
Org Lett; 2001 Jul; 3(15):2317-20. PubMed ID: 11463305
[TBL] [Abstract][Full Text] [Related]
8. Piperidine renin inhibitors: from leads to drug candidates.
Märki HP; Binggeli A; Bittner B; Bohner-Lang V; Breu V; Bur D; Coassolo PH; Clozel JP; D'Arcy A; Doebeli H; Fischli W; Funk CH; Foricher J; Giller T; Grüninger F; Guenzi A; Güller R; Hartung T; Hirth G; Jenny CH; Kansy M; Klinkhammer U; Lave T; Lohri B; Luft FC; Mervaala EM; Müller DN; Müller M; Montavon F; Oefner CH; Qiu C; Reichel A; Sanwald-Ducray P; Scalone M; Schleimer M; Schmid R; Stadler H; Treiber A; Valdenaire O; Vieira E; Waldmeier P; Wiegand-Chou R; Wilhelm M; Wostl W; Zell M; Zell R
Farmaco; 2001; 56(1-2):21-7. PubMed ID: 11347960
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of Plasmodium falciparum aspartic protease inhibition by piperidine derivatives.
Saify ZS; Nisa M; Azhar KF; Azim MK; Rasheed H; Mushtaq N; Arain MA; Haider S; Khanum M; Ahmed W
Nat Prod Res; 2011 Dec; 25(20):1965-8. PubMed ID: 22050275
[TBL] [Abstract][Full Text] [Related]
10. A nonpeptide, piperidine renin inhibitor provides renal and cardiac protection in double-transgenic mice expressing human renin and angiotensinogen genes.
Major TC; Olszewski B; Rosebury W; Okerberg C; Carlson T; Ostroski R; Schroeder R; Kowala MC; Leadley R
Cardiovasc Drugs Ther; 2008 Dec; 22(6):469-78. PubMed ID: 18679781
[TBL] [Abstract][Full Text] [Related]
11. Structure-based design of substituted piperidines as a new class of highly efficacious oral direct Renin inhibitors.
Ehara T; Irie O; Kosaka T; Kanazawa T; Breitenstein W; Grosche P; Ostermann N; Suzuki M; Kawakami S; Konishi K; Hitomi Y; Toyao A; Gunji H; Cumin F; Schiering N; Wagner T; Rigel DF; Webb RL; Maibaum J; Yokokawa F
ACS Med Chem Lett; 2014 Jul; 5(7):787-92. PubMed ID: 25050166
[TBL] [Abstract][Full Text] [Related]
12. The discovery and preparation of disubstituted novel amino-aryl-piperidine-based renin inhibitors.
Cody WL; Holsworth DD; Powell NA; Jalaie M; Zhang E; Wang W; Samas B; Bryant J; Ostroski R; Ryan MJ; Edmunds JJ
Bioorg Med Chem; 2005 Jan; 13(1):59-68. PubMed ID: 15582452
[TBL] [Abstract][Full Text] [Related]
13. Structure-based design of a new series of N-(piperidin-3-yl)pyrimidine-5-carboxamides as renin inhibitors.
Imaeda Y; Tawada M; Suzuki S; Tomimoto M; Kondo M; Tarui N; Sanada T; Kanagawa R; Snell G; Behnke CA; Kubo K; Kuroita T
Bioorg Med Chem; 2016 Nov; 24(22):5771-5780. PubMed ID: 27687967
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of porcine pepsin by two substrate analogues containing statine. The effect of histidine at the P2 subsite on the inhibition of aspartic proteinases.
Maibaum J; Rich DH
J Med Chem; 1988 Mar; 31(3):625-9. PubMed ID: 3126296
[TBL] [Abstract][Full Text] [Related]
15. Effective blocking of HIV-1 proteinase activity by characteristic inhibitors of aspartic proteinases.
Richards AD; Roberts R; Dunn BM; Graves MC; Kay J
FEBS Lett; 1989 Apr; 247(1):113-7. PubMed ID: 2651157
[TBL] [Abstract][Full Text] [Related]
16. Discovery of benzimidazole derivatives as orally active renin inhibitors: Optimization of 3,5-disubstituted piperidine to improve pharmacokinetic profile.
Tokuhara H; Imaeda Y; Fukase Y; Iwanaga K; Taya N; Watanabe K; Kanagawa R; Matsuda K; Kajimoto Y; Kusumoto K; Kondo M; Snell G; Behnke CA; Kuroita T
Bioorg Med Chem; 2018 Jul; 26(12):3261-3286. PubMed ID: 29754833
[TBL] [Abstract][Full Text] [Related]
17. Solid-phase synthesis of aspartic peptidase inhibitors: 3-alkoxy-4-aryl piperidines.
Bursavich MG; Rich DH
Org Lett; 2001 Aug; 3(17):2625-8. PubMed ID: 11506594
[TBL] [Abstract][Full Text] [Related]
18. Piperidine-based renin inhibitors: upper chain optimization.
Corminboeuf O; Bezençon O; Remeň L; Grisostomi C; Richard-Bildstein S; Bur D; Prade L; Strickner P; Hess P; Fischli W; Steiner B; Treiber A
Bioorg Med Chem Lett; 2010 Nov; 20(21):6291-6. PubMed ID: 20843690
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of renin inhibitors in the management of cardiovascular disorders.
Stanton A
Am J Cardiovasc Drugs; 2003; 3(6):389-94. PubMed ID: 14728059
[TBL] [Abstract][Full Text] [Related]
20. Piperidine-renin inhibitors compounds with improved physicochemical properties.
Güller R; Binggeli A; Breu V; Bur D; Fischli W; Hirth G; Jenny C; Kansy M; Montavon F; Müller M; Oefner C; Stadler H; Vieira E; Wilhelm M; Wostl W; Märki HP
Bioorg Med Chem Lett; 1999 May; 9(10):1403-8. PubMed ID: 10360745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
